PKG00283562.docx

This file is an application template for Type 6 applications under RFA-PS-18-000, a Centers for Disease Control and Prevention (CDC) cooperative agreement opportunity focused on injury prevention and control research and state and community-based programs (CFDA 93.136). The application deadline is September 30, 2030, and eligible applicants include state governments, local governments, territorial governments, counties, universities, small businesses, and nonprofit organizations, though only one application per eligible state or territory will be funded. Awards provide financial assistance for an initial 12-month budget period with a performance period of up to five years, contingent on fund availability and satisfactory recipient progress; typical cooperative agreement awards range from $350,000 to $1.4 million annually based on historical CFDA 93.136 data.

Applicants will be evaluated through a two-phase review process. Phase I assesses eligibility and completeness, while Phase II evaluates complete and eligible applications on approach, evaluation and performance measurement capabilities, and organizational capacity to implement proposed strategies. The program funds a broad range of injury and violence prevention activities, including child abuse prevention, sexual violence prevention, firearm-related violence reduction, overdose prevention, and other evidence-based injury prevention practices. Recipients must demonstrate access to state or territory-wide data sources and will be subject to monitoring through required reports, with potential for non-competitive continuation awards based on satisfactory progress. The program is authorized under sections 392(a)(1) of the Public Health Service Act.